A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding

Summary

The study is designed to assess the efficacy and safety of famciclovir 250 mg twice a day (bid) suppressive treatment in men and women with herpes virus type 2 (HSV-2) infection, with and without a reported history of genital herpes and with or without herpes virus type 1 (HSV-1) seropositivity.

Timeline

Start

2004-07

Primary completion

2005-10

Completion

2005-10

Drugs

Indications